Literature DB >> 23673147

Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice.

Mona Lisa Chanda1, Alexander H Tuttle, Inna Baran, Cori Atlin, Daniella Guindi, Georgia Hathaway, Nyrie Israelian, Jeremy Levenstadt, Daniel Low, Lynn Macrae, Louise O'Shea, Alex Silver, Elaina Zendegui, A Mariette Lenselink, Sabine Spijker, Michel D Ferrari, Arn M J M van den Maagdenberg, Jeffrey S Mogil.   

Abstract

Migraine is a highly prevalent, disabling and complex episodic brain disorder whose pathogenesis is poorly understood, due in part to the lack of valid animal models. Here we report behavioral evidence of hallmark migraine features, photophobia and unilateral head pain, in transgenic knock-in mice bearing human familial hemiplegic migraine, type 1 (FHM-1) gain-of-function missense mutations (R192Q or S218L) in the Cacna1a gene encoding the CaV2.1 calcium channel α1 subunit. Photophobia was demonstrated using a modified elevated plus maze in which the safe closed arms were brightly illuminated; mutant mice avoided the light despite showing no differences in the standard (anxiety) version of the test. Multiple behavioral measures suggestive of spontaneous head pain were found in 192Q mutants subjected to novelty and/or restraint stress. These behaviors were: (1) more frequent in mutant versus wildtype mice; (2) lateralized in mutant but not in wildtype mice; (3) more frequent in females versus males; and (4) dose-dependently normalized by systemic administration of 2 different acute analgesics, rizatriptan and morphine. Furthermore, some of these behaviors were found to be more frequent and severe in 218L compared to 192Q mutants, consistent with the clinical presentation in humans. We suggest that Cacna1a transgenic mice can experience migraine-related head pain and can thus serve as unique tools to study the pathogenesis of migraine and test novel antimigraine agents.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673147     DOI: 10.1016/j.pain.2013.03.038

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  27 in total

Review 1.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 2.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 3.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

4.  Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice.

Authors:  Mustafa Balkaya; Jessica L Seidel; Homa Sadeghian; Tao Qin; David Y Chung; Katharina Eikermann-Haerter; Arn M J M van den Maagdenberg; Michel D Ferrari; Cenk Ayata
Journal:  Neuroscience       Date:  2019-07-09       Impact factor: 3.590

5.  Female sex and obesity increase photophobic behavior in mice.

Authors:  Heather L Rossi; Orlando Lara; Ana Recober
Journal:  Neuroscience       Date:  2016-06-17       Impact factor: 3.590

Review 6.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 7.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.

Authors:  Terence J Coderre; André Laferrière
Journal:  J Neural Transm (Vienna)       Date:  2019-11-18       Impact factor: 3.575

8.  Enhanced Thalamocortical Synaptic Transmission and Dysregulation of the Excitatory-Inhibitory Balance at the Thalamocortical Feedforward Inhibitory Microcircuit in a Genetic Mouse Model of Migraine.

Authors:  Angelita Tottene; Morgana Favero; Daniela Pietrobon
Journal:  J Neurosci       Date:  2019-10-23       Impact factor: 6.167

9.  Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Tammy N Hilgendorf; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

Review 10.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.